We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Institutional Corruption and the Pharmaceutical Policy.
- Authors
Rodwin, Marc A.
- Abstract
Today, the goals of pharmaceutical policy and medical practice are often undermined due to institutional corruption -- that is, widespread or systemic practices, usually legal, that undermine an institution's objectives or integrity. In this symposium, 16 articles investigate the corruption of pharmaceutical policy, each taking a different look at the sources of corruption, how it occurs, and what is corrupted. We will see that the pharmaceutical industry's own purposes are often undermined. Furthermore, pharmaceutical industry funding of election campaigns and lobbying skews the legislative process that sets pharmaceutical policy. Moreover, certain practices have corrupted medical research, the production of medical knowledge, the practice of medicine, drug safety, the Food and Drug Administration's oversight of the pharmaceutical market, and the trustworthiness of patient advocacy organizations.
- Subjects
UNITED States; PHARMACEUTICAL policy; CORRUPTION -- Social aspects; PHARMACEUTICAL industry; CORRUPTION; MEDICAL practice; ORGANIZATIONS &; ethics; CLINICAL trials; DRUGS; DRUG laws; HEALTH care reform; LOBBYING; MARKETING; MEDICAL ethics; HEALTH policy; MEDICAL research; ORGANIZATIONAL behavior; PHYSICIANS; PROFESSIONS; RESEARCH ethics; PHARMACY; SOCIAL responsibility; DRUG control; RESEARCH personnel; INVESTIGATIONAL drugs; ETHICS; ECONOMICS
- Publication
Journal of Law, Medicine & Ethics, 2013, Vol 41, Issue 3, p544
- ISSN
1073-1105
- Publication type
Article
- DOI
10.1111/jlme.12062